Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study - 17/05/18
on behalf of the
CROMIS-2 collaborators†
Summary |
Background |
Cerebral microbleeds are a potential neuroimaging biomarker of cerebral small vessel diseases that are prone to intracranial bleeding. We aimed to determine whether presence of cerebral microbleeds can identify patients at high risk of symptomatic intracranial haemorrhage when anticoagulated for atrial fibrillation after recent ischaemic stroke or transient ischaemic attack.
Methods |
Our observational, multicentre, prospective inception cohort study recruited adults aged 18 years or older from 79 hospitals in the UK and one in the Netherlands with atrial fibrillation and recent acute ischaemic stroke or transient ischaemic attack, treated with a vitamin K antagonist or direct oral anticoagulant, and followed up for 24 months using general practitioner and patient postal questionnaires, telephone interviews, hospital visits, and National Health Service digital data on hospital admissions or death. We excluded patients if they could not undergo MRI, had a definite contraindication to anticoagulation, or had previously received therapeutic anticoagulation. The primary outcome was symptomatic intracranial haemorrhage occurring at any time before the final follow-up at 24 months. The log-rank test was used to compare rates of intracranial haemorrhage between those with and without cerebral microbleeds. We developed two prediction models using Cox regression: first, including all predictors associated with intracranial haemorrhage at the 20% level in univariable analysis; and second, including cerebral microbleed presence and HAS-BLED score. We then compared these with the HAS-BLED score alone. This study is registered with ClinicalTrials.gov, number NCT02513316.
Findings |
Between Aug 4, 2011, and July 31, 2015, we recruited 1490 participants of whom follow-up data were available for 1447 (97%), over a mean period of 850 days (SD 373; 3366 patient-years). The symptomatic intracranial haemorrhage rate in patients with cerebral microbleeds was 9·8 per 1000 patient-years (95% CI 4·0–20·3) compared with 2·6 per 1000 patient-years (95% CI 1·1–5·4) in those without cerebral microbleeds (adjusted hazard ratio 3·67, 95% CI 1·27–10·60). Compared with the HAS-BLED score alone (C-index 0·41, 95% CI 0·29–0·53), models including cerebral microbleeds and HAS-BLED (0·66, 0·53–0·80) and cerebral microbleeds, diabetes, anticoagulant type, and HAS-BLED (0·74, 0·60–0·88) predicted symptomatic intracranial haemorrhage significantly better (difference in C-index 0·25, 95% CI 0·07–0·43, p=0·0065; and 0·33, 0·14–0·51, p=0·00059, respectively).
Interpretation |
In patients with atrial fibrillation anticoagulated after recent ischaemic stroke or transient ischaemic attack, cerebral microbleed presence is independently associated with symptomatic intracranial haemorrhage risk and could be used to inform anticoagulation decisions. Large-scale collaborative observational cohort analyses are needed to refine and validate intracranial haemorrhage risk scores incorporating cerebral microbleeds to identify patients at risk of net harm from oral anticoagulation.
Funding |
The Stroke Association and the British Heart Foundation.
Le texte complet de cet article est disponible en PDF.Plan
Vol 17 - N° 6
P. 539-547 - juin 2018 Retour au numéro
Article précédent
- Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry
- Torbjörn Tomson, Dina Battino, Erminio Bonizzoni, John Craig, Dick Lindhout, Emilio Perucca, Anne Sabers, Sanjeev V Thomas, Frank Vajda, EURAP Study Group, Francesca Faravelli, Chiara Pantaleoni, Elisabeth Robert-Gnansia, Leonor Cabral-Lim, Boštjan ?ebular, Alejandro De Marinis, Reetta Kälviäinen, Ketevan Khomeriki, Gordana Kiteva-Trencevska, Silvia Kochen, Martin Kurthen, Gerhard Luef, Meritxell Martinez Ferri, Maja Milovanovi?, Karl Otto Nakken, Miri Neufeld, Hideyuki Ohtani, Aline Russell, Vladimír Safcák, Bettina Schmitz, Luigi Maria Specchio, Barbara Tettenborn, Eugene van Puijenbroek, Hsiang-Yu Yu, Jana Zarubova, Claus Albretsen, Silje Alvestad, Noemi Becser Andersen, Luisa Antonini, Jens Arentsen, Dag Aurlien, Ismael Barzinji, Juan Luis Becerra Cuñat, Natalia Bohorquez Morera, Martin J. Brodie, Eylert Brodtkorb, Laura Broglio, Elsebeth Bruun Christensen, Petr Bušek, Claudia Cagnetti, Maria Paola Canevini, Astrid Carius, Maria Dolores Castro Vilanova, Michela Cecconi, T-Y Chang, Jakob Christensen, Giovanni De Maria, Dieter Dennig, Brenda Diputado, Janne Marit Ertresvåg, Toni Escartin, Dominique Flügel, Birgitte Forsom Sondal, Nicoletta Foschi, Albertina Franza, Katsuyuki Fukushima, Antonio Gambardella, Iñigo Garamendi Ruiz, Helena Gauffin, Pia Gellert, Leif Gjerstad, Lisa Gordon, Katrine Haggag, Imad Halawa, Terttu Heikinheimo-Connell, Tim Hendgen, Zarouhi Hertz, Odo Hildenhagen, Stephanie Hödl, Ineke Hogenesch, Anette Huuse Farmen, Yushi Inoue, Stefan Juhl, Masaaki Kato, Germaine Kenou Van Rijckevorssel, E. Kluck, Hana Krijtová, Eva Kumlien, Angelo Labate, Theresa Lasch, Hans Lindsten, Renata Listonova, Rasmus Lossius, Anders Lundgren, Kristina Malmgren, Iva Mare?ková, Daniela Marino, Peter Mattsson, Aileen McGonigal, Katarzyna Miesczanleh, Masahiro Mizobuchi, Barbara Mostacci, Birgit Müffelmann, Uden Navn, Anders Nilsson, Bernhard Oehl, Andrea Ortenzi, Judith Osseforth, Aldo Paggi, Eliana Pastor, Birthe Pedersen, Vaiva Petrenaite, Pietro Pignatta, Isabel Pires, Alessandra Pistelli, Jesús Antonio Riuz Gimenez, Raffaele Rocchi, Lone Rodam, Reina Roivainen, Gisela Rytí?ová, Christian Samsonsen, Gemma Sansa Fayos, Anna Maija Saukkonen, Alma Sikiric, David Sopelana Garay, Bernhard Steinhoff, Maria Strandberg, Torleiv Svendsen, Erik Tauboll, Kiyohito Terada, Marina Trivisano, Katherine Turner, Mogens Worm, Elias Zakharia, Elena Zambrelli, Morteza Zarifi-Oskoie
- Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study
- Cyril Pottier, Xiaolai Zhou, Ralph B Perkerson, Matt Baker, Gregory D Jenkins, Daniel J Serie, Roberta Ghidoni, Luisa Benussi, Giuliano Binetti, Adolfo López de Munain, Miren Zulaica, Fermin Moreno, Isabelle Le Ber, Florence Pasquier, Didier Hannequin, Raquel Sánchez-Valle, Anna Antonell, Albert Lladó, Tammee M Parsons, NiCole A Finch, Elizabeth C Finger, Carol F Lippa, Edward D Huey, Manuela Neumann, Peter Heutink, Matthis Synofzik, Carlo Wilke, Robert A Rissman, Jaroslaw Slawek, Emilia Sitek, Peter Johannsen, Jørgen E Nielsen, Yingxue Ren, Marka van Blitterswijk, Mariely DeJesus-Hernandez, Elizabeth Christopher, Melissa E Murray, Kevin F Bieniek, Bret M Evers, Camilla Ferrari, Sara Rollinson, Anna Richardson, Elio Scarpini, Giorgio G Fumagalli, Alessandro Padovani, John Hardy, Parastoo Momeni, Raffaele Ferrari, Francesca Frangipane, Raffaele Maletta, Maria Anfossi, Maura Gallo, Leonard Petrucelli, EunRan Suh, Oscar L Lopez, Tsz H Wong, Jeroen G J van Rooij, Harro Seelaar, Simon Mead, Richard J Caselli, Eric M Reiman, Marwan Noel Sabbagh, Mads Kjolby, Anders Nykjaer, Anna M Karydas, Adam L Boxer, Lea T Grinberg, Jordan Grafman, Salvatore Spina, Adrian Oblak, M-Marsel Mesulam, Sandra Weintraub, Changiz Geula, John R Hodges, Olivier Piguet, William S Brooks, David J Irwin, John Q Trojanowski, Edward B Lee, Keith A Josephs, Joseph E Parisi, Nilüfer Ertekin-Taner, David S Knopman, Benedetta Nacmias, Irene Piaceri, Silvia Bagnoli, Sandro Sorbi, Marla Gearing, Jonathan Glass, Thomas G Beach, Sandra E Black, Mario Masellis, Ekaterina Rogaeva, Jean-Paul Vonsattel, Lawrence S Honig, Julia Kofler, Amalia C Bruni, Julie Snowden, David Mann, Stuart Pickering-Brown, Janine Diehl-Schmid, Juliane Winkelmann, Daniela Galimberti, Caroline Graff, Linn Öijerstedt, Claire Troakes, Safa Al-Sarraj, Carlos Cruchaga, Nigel J Cairns, Jonathan D Rohrer, Glenda M Halliday, John B Kwok, John C van Swieten, Charles L White, Bernardino Ghetti, Jill R Murell, Ian R A Mackenzie, Ging-Yuek R Hsiung, Barbara Borroni, Giacomina Rossi, Fabrizio Tagliavini, Zbigniew K Wszolek, Ronald C Petersen, Eileen H Bigio, Murray Grossman, Vivianna M Van Deerlin, William W Seeley, Bruce L Miller, Neill R Graff-Radford, Bradley F Boeve, Dennis W Dickson, Joanna M Biernacka, Rosa Rademakers
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?